این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
شنبه 22 آذر 1404
Iranian Journal of Medical Sciences
، جلد ۲۸، شماره ۱، صفحات ۳۷-۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Evaluation of a New Anti-HIV1/2 ELISA–HIV 1/2 REC Diagnostic Kit Based on E. coli Derived Soluble Recombinant Proteins: Ex-perience of an International Study
چکیده انگلیسی مقاله
Background/Objective: Development of a new enzyme-linked immunosorbent assay (ELISA) for screening human blood serum and plasma for antibodies to human immunodeficiency virus type 1 (HIV1) and type 2 (HIV2) as HIV1/2REC ELISA diagnostic kit based on E. coli derived soluble recombinant proteins. Methods : Polypeptides corresponding to HIV1 gp41 and HIV2 gp36 immunodominant regions and HIV1 gag were expressed in E. coli in fusion with thioredoxin (Trx) to obtain a highly purified (>98%) soluble refolded proteins, which was used as solid phase antigens for ELISA. Results: The sensitivity and specificity of anti-HIV1/2 antibody detection were evaluated with representative panels of positive and negative sera. Positive panels included HIV1-positive Western-blot (WB)-confirmed specimens collected in Iran, Russia, and Uganda. Commercially available HIV1 and HIV2 seroconversion low titer and performance panels were also used. Negative panel was collected from random volunteer blood donors, risk group members, HCV-infected patients and individuals with non-HIV related conditions potentially influencing test results. The sensitivity of antibody detection with new kit was determined to be 100%. Specificity was determined to be 99.82%. It was shown than thioredoxin (Trx) did not change the immunodominant epitopes of HIV. These fusion proteins are recognized by human native antibodies. In addition, thioredoxin (Trx) would help natural refolding of HIV proteins by E. coli . Conclusion : These characteristics of the new assay are comparable to those of majority of FDA-licensed and officially approved European diagnostic kits, which are currently available in the United States and Europe.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
irina a نیکلایوا | irina a nikolaeva
institute of immunology, moscow, russia
فریدون مهبودی | fereidoun mahboudi
biotechnology research center pas-teur institute of iran, tehran, iran
الکساندر chevalier | alexander chevalier
institute of immunology, moscow, russia
قادر خلیلی | ghader khalili
biotechnology research center pas-teur institute of iran, tehran, iran
علیرضا خادم | alireza khadem
biotechnology research center pas-teur institute of iran, tehran, iran
اله v somova | alla v somova
scientific center for hematology, moscow, russia
steven tugume buguruca | steven tugume buguruca
central military hospital, kampala, uganda
igor g sidorovich | igor g sidorovich
institute of immunology, moscow, russia
نشانی اینترنتی
http://ijms.sums.ac.ir/index.php/IJMS/article/view/2425
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
Original Article(s)
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات